Non-invasive methods for routine monitoring of reproductive states and reproduction control in large colonies of captive Collithrix iacchus have been developed. Immunoactive urinary oestrone-3-conjugates (E]C) were measured during non-conception cycles (n=S) and pregnancy In=7). Using plasma progesterone levels to time ovulation, ovulation was quantitatively estimated by al calculating the first EtC rise and b) by establishing an E]C threshold. Ovulation was thus defined as taking place 4 days preceding al the first rise of E]C above follicular-phase levels, or b) a concentration~4.5 J.lgE]C/mg creatinine. Early pregnancy could be determined after day 20 by continued luteal-phase levels of E]C. Secondly, the luteolytic effect of cloprostenol, injected over a wide range of doses and between days 1 and 64 after ovulation/ conception, was analysed. Luteolysis was achieved when cloprostenol was administered after day 5 post-ovulation; the luteolytic effect was found not to be dose-dependent. The success of cloprostenol treatment was 87% as confirmed by endocrine monitoring. The methods described are effective and minimize intervention, and are therefore suitable for long-term applications, particularly in combination with behavioural studies.
reproduction. In common with most New World primates, marmosets do not menstruate nor do they show other external indications of the sexual cycle (Rothe 1975) .
Therefore, the detection of ovulation and pregnancy is best achieved by endocr~ne monitoring (Hearn 1983) .
The endocrinology of the female marmoset is well described (Hodges 1988) . Peripheral blood concentrations of oestrogen and progesterone have been measured across the ovarian cycle (Harding et a1. 1982 , Harlowet aL 1984 , Hearn 1980 , Hodges &. Hearn 1983 and pregnancy (Hodges et oL 1983b) , demonstrating an ovarian cycle length of 28.63± 1.01 days (mean±SEM), consisting of a follicular phase of 8.25 ± 0.30 days and a luteal phase of 19.22±0.63 days (Harlow et laboratory Animals (1996 ) 30,162-170 al. 1983 ) and a pregnancy of 144 days (range: 141-146) (Chambers &. Hearn 1979) .Furthermore, oestrogen and progesterone metabolites have been measured in urine samples , Heger &. Neubert 1987 , Hodges et al. 1983a , Lunn 1987 , Shackleton 1974 ,and recently in faecal samples (Heistermann et al. 1993). Sex steroid determinations in urine and faecal samples permit non-invasive collection techniques without stressful handling of animals, and have proven useful in these small primates in which repeated blood sampling is difficult. Although extensive data le.g. cycle and pregnancy profiles) derived from the measurement of reproductive steroid metabolites in urine of female common marmosets have been published, little information is available on routine application of these non-invasive methods in either the life sciences or animal management (Heger &. Neubert 1988) . Against this background, the principal aim of the present study was to develop a quantitative, reliable and noninvasive method for estimating the day of ovulation and monitoring reproductive state in the common marmoset. This method was based on the radioimmunoassay for urinary oestrone-3-conjugates (EIC) described by Eastman et al. (1984) . Secondly, we further applied the method in conjunction with an established method of reproduction control (Summers et al. 1985l ,to ascertain the latter's suitability for routine breeding management in marmoset colonies.
Materials and methods

Animals
Eleven sexually mature captive-bred female common marmosets, maintained in the laboratory primate colony of the Anthropology Institute, University of Zurich (Switzerland), were used in this study which was carried out between February 1992 and April 1995. Details of animal management were described by Pryce et al. (1993) .The body weight of the adult monkeys ranged from 0.28 to 0.51 kg. Normally, the marmosets were paired with intact males and lived in single family groups. For the specific purposes 163 of this study, some females were kept isolated around the periovulatory phase in order to prevent conception. Cages measured 2 x 1 x 2 m, could be entered by personnel, and contained a removable sleeping box which allowed, without handling, routine transport (Hearn 1978) of trained animals for sample collection.
Cloprostenol treatment
In our laboratory, early pregnancies are terminated routinely by induction of luteal regression (Summers et al. 1985) with cloprostenol, a prostaglandin F 2a analogue (Estrumate: Coopers, Swiss Serum and Vaccine Institute, Bern). For the present study, subjects were treated between day one after ovulation and day 64 of pregnancy with an intramuscular injection of cloprostenol at doses ranging from 1.2 to 50 Jlgjkg bodyweight. Each of the 11 females received dosages of cloprostenol across this range according to a randomized schedule. Doses >30 J1g cloprostenol were administered in a . split dose with a I-h interval. This was done to minimize the incidence of cloprostenol short-term adverse effects which are dosedependent in the marmoset (vomiting, defaecation, straining, rapid respiration: (Summers et al. 1985) ).Day of ovulation was estimated according to the E1C threshold established in this study. Luteolysis was defined for luteal phases and pregnancies as return of follicularphase levels of urinary EIC within days 2 and 8 following treatment. Given that the placenta assumes the major role of steroid secretion at about day SO (Hodges et al. 1983b) , luteolysis was unlikely to have been the cause of abortion in the small proportion of cloprostenol treatments performed around and after day 50. For convenience only, therefore, all cloprostenol treatments that resulted in the termination of pregnancy are called luteolytic below. In pregnancies of at least 4 weeks duration, luteolysis was also assessed by uterine palpation (Hearn 1977b) .
In a small number of cases, reproductive state was also assessed by ultrasound scanning (UltraMark 9, ATL, Washington, USAl, carried out at the University Veterinary Hospital Zurich, using a sector-scan head of either 7.5 or lOMHz (Oerke et al. 1993) . In instances where the injection was assessed not to be luteolytic, treatment was repeated 3-4 days later, using twice the amount of cloprostenol, and the process continued untilluteolysis occurred. A total of 160 cloprostenol treatments were performed and the relationship between day of treatment relative to ovulation, dosage and luteolysis induction was determined.
Sample collection
Blood samples Matched blood and urine samples were obtained daily from 5 study females. Sampling began 4 days after cloprostenol-induced luteolysis and continued until ovulation was confirmed, as demonstrated by increased progesterone concentrations. Blood samples were taken immediately after urine collection via puncture of the femoral vein of unsedated, trained animals held in a simple restraint apparatus (Hearn 1977a ) using a heparinized 1ml syringe. Blood samples (0.2 ml) were placed directly on ice, and within 30 min the plasma was separated by centrifugation at 1500 x g for 20 min. Plasma was stored at -25°C prior to progesterone RIA.
Urine samples Morning (09.00h) urine samples were collected and analysed fortheir content of immunoactive E1C. Samples were collected daily during blood sampling and 3 times weekly otherwise. Animals were trained to enter the transportable sleeping box and immediately transferred to a metabolism cage (24 x 26 x 40 cm). The collection of at least 0.2 ml urine, sufficient for the study aims, was usually achieved in less than 30 min. To minimize faecal contamination, the metabolism cage contained 2 floors: a perforated metal grid on which the animal stood and which was pervious to urine and below this, a PVC floor which sloped to act as a funnel. A clean 1ml cryotube was fitted under the funnel and the urine was stored at -25°C until further processing.
Creatinine determination
To compensate for variations in urine volume and concentration (Bos et al. 1993) , the creatinine (Cr) content of each urine sample
Nievergelt & Pryce was determined using a Beckman Creatinine Analysor 2 (Beckman instruments, Inc, Fullerton, CAl. The samples had to be diluted 1:10 or 1:20 according to their visually inspected concentration. Inter-assay precision was 2% (n=24J. Urinary hormone levels were divided by the Cr concentration and thus expressed as mass/mg Cr.
Hormone assays
Plasma progesterone Progesterone was extracted from plasma in duplicate by shaking 20 III of plasma, made up to 100 III with Pas-Gel buffer, with 30 volumes of petroleum ether for 20 min. The mean efficiency of each extraction was monitored by adding 1500 c.p.m. of [3H]progesterone to 6 separate tubes, giving a grand mean of 70±6% (n=4). Progesterone was measured in the doubleantibody iodinated RIA described and validated in Pryce et al. (19931. The day of ovulation [day 01was defined as the day preceding the rise of peripheral blood progesterone concentrations above 10 ngfml (Harlow et al. 1983 ).
Urinary oestrone-3-conjugates
A direct non-specific RIA was used to measure E1C in urine IEastman et al. 1984) . The antiserum was raised in a rabbit against oestrone-p-Dglucuronide sodium salt-BSA and cross-reacted 96.6% with oestrone-3-sulphate, 0.75% with oestradiol-3-sulphate, 8.3% with oestradiol-17P, l.0% with oestradiol-l7o:, 0.25% with oestriol, 200.0% with oestrone, 0.03% with androstenodione, 0.04% with progesterone and <0.01 % with other steroids tested. Urine samples were diluted with tricinebuffered saline (pH 7.0) between 1:10 to 1:600, according to urinary concentration and the reproductive state of the female. Duplicate aliquots (5Ill) of diluted urine were incubated for 1h at 3rc with 100 III antiserum (1:40 000 dilution) and 100 JlI [6,7-3H(N)]oestrone-3-sulphate, ammonium salt (specific activity SOJlCi/nmol, 100 Jll containing approx. 8000 c.p.m.). Separation of bound and unbound fractions was performed by incubation with 500 JlI dextran-charcoal (0.1 g dextran T-70 and l.Og charcoal in 100mi buffer) at 4°C for 10 min. Doubling dilutions of E I -3 sulphate (E0879, Sigma) were assayed in triplicate over a range of I5.6-1000pg/1001l1 as standard.
Validation parameters of the assay were found to have the following values, expressed as coefficient of variation (n): dilution precision for replicates of a urine pool diluted 1:300 and incubated in different assays=lO% (25),interassay precision=7% (36)and 9% (36) (high and low pools, respectively) and intraassay precision=4% (9)(early pregnancy pool). Accuracy, determined by the percentage recovery of known amounts of E 1 S standard added to urine samples containing low levels of immunoactivity, was 1l0.i±3.6% (mean± SEM, n=I8). The sensitivity of the assay at 90% binding was I8.2pg. There was no deviation from parallelism (P>0.2, between changes in percent binding obtained with serially diluted urine. samples (n=4) and those obtained with the standard curve.
Data analysis
To define the post-ovulatory E 1 C concentration rise, the modified cumulative sum (cusum) method was applied (Royston 1983 ): For each cycle, the mean E1C/Cr concentration between days -7 to -1 was log transformed (loge)to provide the cycle's baseline. The standard deviation (SD)of the 9 baselines of the 9 study cycles was calculated, and the reference was taken as (2.5SD+cycle baseline). The decision interval used for significant rise detection was 5 SD. Beginning with the day of ovulation (determined by progesterone levels), the difference between loge (E 1 C/Cr) on this day and the reference was calculated and the value (loge (E 1 C/Cr) day a-reference) gave the cusum on day O.If cusum at qay a was greater than the decision interval, EICICr had demonstrated a significant rise on day O.If cusum was less than the decision interval, then cusum day a was carried forward to day 1, resetting to zero in the case of a negative value. The difference between loge (E\C/Cr) on day 1 and the reference was calculated, added to cusum day 0 to give cusum day 1 and compared with the decision interval. Calculation continued until, on a particular day post-ovulation, cusum exceeded the 165 decision interval. Once this occurred, the first post-ovulatory concentration rise was defined by counting back to the first day loge (E 1 C/Cr) exceeded the reference.
A threshold level of E1C/Cr was selected by comparing the E1C concentrations of the 9 cycles at the day of the first rise. The E 1 C concentration which (1) most cycles had exceeded at the day of the first rise and (2) most cycles had not reached the day before the first rise, was chosen as threshold.
For cycles analysed on the basis of samples collected 3 times per week only, ovulation was estimated and data points were then grouped to 3 points per week. Comparisons between non-fertile and fertile cycles/pregnancies were made using grouped time points. Data were analysed using Student's unpaired t-test at a significance level of 0.05.
Results
Timing of ovulation
Daily plasma progesterone levels of 9 cycles (N=5 animals) were used to determine the day of ovulation (day 0). A comparison with E1C/ Cr concentrations of matched urine samples is shown in Fig. 1 . The cusum method was applied to detect the first concentration rise of EIC/Cr and parameters were found to have the following values: mean baseline values ranged from -0.37 to 0.21 (logellgE1C/mg Cr); SD of the transformed baseline means (n=9) was 0.41, thus giving cycle-specific reference values of (baseline+ 1.011 (where 1.01=2.5 SDt and a decision interval of 2.02 (=5SD). In the 8 cycles for which cusum analysis was performed (the cusum of the ninth cycle could not be calculated due to a missing urine sample), the first rise of urinary E1CICr concentrations during the periovulatory phase occurred on day 4 in 5 cycles and on day 3 in 3 cycles. Accordingly, ovulation was defined by cusum analysis as taking place 3-4 days before the first EICICr rise. In a second approach, EIC/Cr on day 4 was used to establish an E1C threshold level. A threshold of 4.5 J1gE1C/mg Cr was reached on day 4 after ovulation in 7 of 9 cycles from 5 different females and on day 3 and day 5 in one cycle each, thus showing similar results as obtained by application of the cusum method to the same data. Ovulation was timed at 4 days preceding the day on which concentrations exceeded threshold. The method was then applied to randomly selected marmosets from 2 other colonies (Institute of Psychology, University of Zurich (N=3) and Ciba AG, Basel (N=3)). These marmosets excreted comparable amounts of EICICr during the follicular phase, and the threshold could be applied to estimate the day of ovulation (data not shown).
The threshold method based on daily urine samples was applied to the same data, but based on samples collected on 3 fixed weekdays only. The results obtained showed similar distributions as for daily collected samples, with 5 cycles reaching threshold at day 4 and 4 cycles at day 5. This method with a sampling frequency of 3 times per week was used throughout the remainder of the study. Figure 2 shows the concentrations of urinary E1CICr expressed as mean I± SEM) during 5 non-fertile cycles and 7 pregnancies, with ovulation estimated by the threshold method. The follicular phase was defined as the period between the day on which EIC concentration decreased below 4.5 J1g/mg Cr and the day of estimated ovulation; the luteal phase was defined as the remaining period of the nonfertile cycle. The durations (mean ± SEM, n=5) of ovarian cycle, follicular phase and luteal phase were 28.25 ± 1.18 days, 10.75 ± 2.20 days and 18.00 ± 1.01 days, respectively. During the non-conception cycle, levels of E 1 C reached a mean peak of 31.35 (± 5.62) j!g/mg Cr on day 10. After day 10 levels decreased gradually and all cycles had reached follicular-phase levels by day 20. Therefore, ovarian cycles with E 1 C concentrations exceeding the threshold after day 20 were considered to be conception cycles.
Er3-con;ugate levels during ovarian cycle and pregnancy
During conception cycles, mean E 1 C showed a similar pattern to non-conception cycles until day 10 post-ovulation. Levels increased gradually thereafter and between weeks 8 and 14 were significantly higher (P<0.05, t-test) than in the luteal phase of non-fertile cycles. After week 14, levels decreased gradually to 34.83 ±3.9 j!g/mg Cr on week 17, when there was a second increase until parturition. E1C declined from approximately 50 j!g/mg Cr to follicularphase levels within 3 days after birth. The gestation length was estimated at 143.14±0.80 days (mean±SEM, N=7).
In one case, a female showed similar E 1 C levels to pregnant animals, and although ultrasound scanning allowed a corpus luteum to be identified, both uterine palpation and ultrasound indicated the absence of a conceptus. This female demonstrated pregnancylike E 1 C levels up to week 24 post-ovulation, when cloprostenol was administered to induce luteolysis.
Cloprostenol induced luteolysis
Eleven females were treated with cloprostenol to induce luteolysis. Figure 3 shows treatment occurred between days 1 to 64 after ovulation and at a dose of 1.2 to 50 j!g/kg bodyweight. 86.88% from a total of 160 treatments resulted in a successful regression of the corpus luteum, defined as a reduction in the urinary concentration of E 1 C to below 4.5 j!g/mg Cr and maintained to at least day 7 post-treatment. Cloprostenol was not luteolytic between days 1 and 4 after ovulation (n=4 treatments, N=3 animals), but caused luteolysis in all females between days 6 and 20 (n=25, N=8). Treatment of animals with confirmed conception cycles (n=131, N=ll) resulted in 87.02 % luteolysis. Successful (n=1l4, N=ll) and unsuccessful (n=17, N=8) treatments of fertile cycles showed no significant difference IP>0.12, t-test) in the mean (±SEM) amount of cloprostenol injected (9.18 ±0.88 and 5.53 ± 1.09 j!g/kg bodyweight, respectively), but cloprostenol was administered significantly earlier (P<0.05, t-test) (in relation to the time of the preceding ovulation) in successful (33.87±0.86d, range 21-64) than in unsuccessful treatments (38.53 ± 1.70 d, range 28-53). There appeared to be inter-female variation in the frequency of treatment success, with one female showing a 29% failure of 1uteolysis (total of 24 treatments) and two females showing no failure at all (combined total of 19 treatments). The average interval from cloprostenol treatment to next ovulation was 11.59±0.19 days (range 7-18, n=137, N=lll and was not significantly different in cycles with low 11.2-6J1gjkg bodyweight, n=76) and high (7-50 J1gjkgbodyweight, n=61) doses (P>0.15, t-test) . Figure 4 shows the pattern of E1C excretion by a female across 6 successive cloprostenol induced luteolysis.
Discussion
The present study has established a quantitative non-invasive method to estimate ovulation and describes the reproductive cycle in the common marmoset. Urinary E[C concentrations increased at 4 days postovulation, thus allowing a retrospective determination of ovulation that is as informative as the existing invasive and quantitative estimate using plasma progesterone (Harlow et a1. 1984) . In contrast to most other studies, we used a statistical method (Royston 1983) to detect the first rise of hormone concentration. Application of a threshold value to estimate the day of ovulation has the practical advantage of allowing reduction of the sampling frequency without any apparent loss of estimate precision. In comparison to the only previous study with similar aims to this one (Heger & Neubert 1988L the direct RIA of oestrogen metabolites is a more practical method than the measurement of progesterone metabolites by chromatographic separation and fluorometry. The present finding of only negligible intra-and interfemale variation in the urinary hormone concentrations for our colony (N=ll), as well as randomly selected marmosets from 2 other colonies (N=6), is particularly encouraging, given that urinary E[C values have to be corrected for volume/concentration variation using creatinine.
Estimates obtained for cycle and pregnancy duration are consistent with other studies (Chambers & Hearn 1979 , Harlow et a1. 1983 . EjC/Cr levels could also be used to distinguish fertile and non-fertile cycles; in the former, the high luteal-phase levels so so 100
ISO 200 Day of study 250 continued after day 20. Day 20 lies within the range of other methods of early pregnancy diagnosis: at day 16 via measurement of circulating chorionic gonadotrophin (CG) (Hearn et a1. 1988L at day 28 via uterine palpation (Hearn 1977b ) and at day 15 after ovulation via ultrasonography (Oerke et a1. 1993) . We found E[C/Cr levels similar to those reported by Eastman et a1. (1984) during non-fertile cycles. However, in contrast to these authors, we found significantly higher E[C/Cr concentrations between days 50 and 100 of pregnancy than during the luteal phase of non-conception cycles. Measurement of a single sample collected within this part of the gestation period could be used to detect pregnancy. However, similar E[C/Cr concentrations to these of the gestation period were also found in a non-pregnant female with probable persistent corpus luteum syndrome (J.K.Hodges, person. comm.) and we recommend uterine palpation to confirm pregnancy in addition to endocrine monitoring. Therefore, measurement of urinary E[C;Cr proved to be a most valuable method for estimating day of ovulation and monitoring reproductive state in the common marmoset. The luteolytic effect of cloprostenol was tested with a view to its application in routine colony management. Cloprostenol has been shown to cause luteolysis in the common marmoset (Summers et a1. 1985) , to act by depriving the corpus luteum of luteotrophic support (Michael et a1. 1993, Webley et a1. 19911 and has been used to control the timing of ovulation (Hodges et a1. 1987) . In agreement with and Summers et a1. (1985) , we found cloprostenol to be a non-luteolytic in the early luteal phase (days 1 to 4), at a time when the corpus luteum is a relatively immature gland, but cloprostenol was luteolytic in all cases of administration between days 6 and 20 after ovulation. However, in contrast to the findings reported by Summers et a1. (1985L in 13% of 131 treatments cloprostenol did not induce a permanent luteolysis when administered during pregnancy (days 21 to 64). Injections of higher doses than recommended in other studies, (e.g. Summers et a1. 1985 ) did not increase the success rate. We did find that successful treatments were administered earlier on average than unsuccessful treatments. Our results also suggest inter-female variation in terms of the success rate of cloprostenol-induced luteolysis, although with only 11 animals in the present study it is not possible as yet to exclude the possibility of bias from good or bad responders in this group. Repeated cloprostenol treatments across 3 or more years showed no adverse effects in any female; for instance, no behavioural or endocrine changes were found. Females conceived immediately after cessation of regular cloprostenol-induced pregnancy termination and went on to deliver viable infants. Mean post-treatment ovulation occurred on day II, which is in agreement with other studies (e.g. Hodges et al. 1987) . Cloprostenol, administered at minimal doses between weeks 4 and 6 postovulation, and used in combination with other methods (endocrine monitoring, uterine palpation or ultrasonography) can be used to control colony size.
In conclusion, the methods we describe here are effective and can be applied routinely over long periods, thus representing a combination of factors which are advantageous in situations where common marmosets are to be managed and studied with a combination of maximal information and minimal intervention, e.g. behavioural studies.
